Clemizole hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H20ClN3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85W6I13D8M, chemically known as benzimidazole, 1-(p-chlorobenzyl)-2-(1-pyrrolidinylmethyl)-, monohydrochloride but more generally known as clemizole hydrochloride, which bears US NIH Compound Identifier 14412. European Medicines Agency schedules Clemizole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01336MIG. Most nations, for tariff and trade purposes, schedule clemizole hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, CLEMIZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Clemizole hydrochloride bears US NLM identifiers UMLS ID C2825478 and NCI Concept Code C81152. SMILES: C1CCC2C(C1)NC(N2CC3CCC(CC3)CL)CN4CCCC4.CL.